Fabry disease (FD) causes myocardial native T1 lowering on cardiac magnetic resonance
(CMR), left ventricular hypertrophy (LVH), and late gadolinium enhancement (LGE). LVH is …

Abstract Aims Cardiac involvement in Fabry disease (FD) occurs prior to left ventricular
hypertrophy (LVH) and is characterized by low myocardial native T1 with sphingolipid …

Background: Cardiovascular magnetic resonance can demonstrate myocardial processes in
Fabry disease (FD), such as low native T1 (sphingolipid storage) and late gadolinium …

A54-year-old man presented with dyspnea on effort. Echocardiogram revealed reduced
apical wall motion of the left ventricle (LV) with extreme hypertrophy of the interventricular …

Background—Fabry disease (FD) is an X-linked disorder of lysosomal metabolism affecting
multiple organs with cardiac disease being the leading cause of death. Current imaging …

Background Cardiac involvement is the leading cause of mortality in patients with Fabry
disease. Identification of imaging findings that predict adverse cardiac events is needed to …

Background Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is
decreased in patients with Fabry disease even before left ventricular hypertrophy (LVH) …

Background Cardiovascular magnetic resonance (CMR) with late gadolinium enhancement
(LGE) imaging is increasingly used to assess myocardial involvement in patients with Fabry …

A54-year-old man presented with dyspnea on effort. Echocardiogram revealed reduced
apical wall motion of the left ventricle (LV) with extreme hypertrophy of the interventricular …

Abstract Introduction About 50% of Fabry disease (FD) patients develop cardiac
manifestation, also known as Fabry cardiomyopathy. Beside echocardiography, cardiac …